Marshall Wace
PRPH

Marshall Wace’s ProPhase Labs PRPH Stock Holding History

Marshall Wace’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,126
Closed -$81.7K – 2574
2023
Q2 		$81.7K Sell
1,126
-4,082
-78% -$332K ﹤0.01% 2342
2023
Q1 		$397K Sell
5,208
-3,705
-42% -$299K ﹤0.01% 2192
2022
Q4 		$858K Buy
8,913
+304
+4% +$32.8K ﹤0.01% 2153
2022
Q3 		$971K Buy
8,609
+5,097
+145% +$593K ﹤0.01% 2424
2022
Q2 		$446K Buy
+3,512
New +$309K ﹤0.01% 2844
2021
Q4 		– Sell
-2,280
Closed -$119K – 4203
2021
Q3 		$119K Buy
+2,280
New +$136K ﹤0.01% 2870
2021
Q2 		– Sell
-5,075
Closed -$375K – 2996
2021
Q1 		$375K Buy
+5,075
New +$487K ﹤0.01% 2047

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Marshall Wace's PRPH Position: Q3 2023 in Review

Marshall Wace sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 1,126 shares — an estimated $81.7K sold.

Marshall Wace first reported a position in PRPH in Q1 2021 and held it in 7 quarters. The position peaked at $971K in Q3 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

  • Marshall Wace reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 1,126 ProPhase Labs shares in Q3 2023, an estimated $81.7K.
  • Marshall Wace first reported a position in ProPhase Labs in Q1 2021 and held it in 7 quarters.
  • Marshall Wace's ProPhase Labs position peaked at $971K in Q3 2022.
  • 35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.